Product News and Recalls

Benicar Maker Daiichi Sankyo to Lay Off 16% of US Staff

benicar maker to lay off employeesPharmaceutical giant Daiichi Sankyo, maker of the blood pressure drug Benicar, will begin laying off 16 percent of its U.S. staff at its headquarters in Parsippany, NJ. The company has also announced plans to cut even more staff starting in mid-April.

Sankyo’s most recent nine-month report indicates that the company’s North American revenue increased 6 percent from the previous year but fell by 1.5 percent in terms of local ...

continue reading...

MO Court Reverses Ruling in Potentially Massive Asbestos Lawsuit

asbestos lawsuit allowed to continue in missouriThe Missouri Court of Appeals has reversed a ruling that denied class certification in a five-year-old asbestos lawsuit brought against Jackson County and a contractor. The lawsuit was filed in 2010 on behalf of thousands of people potentially exposed to asbestos in the Jackson County Courthouse in Kansas City. The new ruling will allow anyone who worked in the courthouse for more than two consecutive weeks or for 80 ...

continue reading...

Toyota Re-recalls 766,300 Vehicles for Airbag Shrapnel

Toyota to recall hundreds of thousands of vehicles for shrapnel risk from airbagsToyota is recalling 766,300 cars and trucks in the United States for continued risk of shrapnel from passenger-side airbags. Toyota recalled vehicles in April 2013 for the same issue, but has discovered that the supplier, the Takata Corporation, may not have provided a comprehensive list of all of the cars that were potentially affected.

These recalls are because of improper manufacturing of Takata ...

continue reading...

PA to Receive $90,000 of $39 Million Daiichi Sankyo Settlement

benicar maker settles case for 39 million dollarsPennsylvania will receive $90,000 of the $39 million that Daiichi Sankyo must pay in damages and penalties to 49 U.S. states, Washington, DC, and the federal government. The National Association of Medicaid Fraud Control and the federal government recently reached the settlement with Daiichi Sankyo after the New Jersey–based pharmaceutical giant was found to have violated federal law in promoting their drugs Azor, Welchol, Tribenzor, and Benicar.

A former ...

continue reading...

Study Finds Change in Law Linked to More Unsafe Drugs

A new study found that prescription drug safety issues have increased with the passage of the Prescription Drug User Fee Act in 1992. The Act has allowed for an accelerated drug approval process. The law allows drug makers to pay to expedite the FDA approval of new prescription medications.

The report examined all of the drugs that were approved by the FDA from 1975 to 2009 and looked at the drugs that received black-box warnings for lethal ...

continue reading...

New AstraZeneca Study Shows Mixed Results for Blood-Thinning Drug

The results of AstraZeneca’s recent trials for its blood-thinning drug Brilinta show a decreased risk of post–heart attack heart problems but an increased risk of major bleeding after using the drug. The pharmaceutical company’s large-scale PEGASUS-TIMI 54 trial included 21,000 patients who had suffered at least one heart attack in the past three years. Patients received either a high dose of Brilinta, a low dose of Brilinta, or a placebo drug. All patients additionally received aspirin ...

continue reading...
Page 1 of 229 12345...»